Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study.

Autor: Alberts, David S., Dahlberg, Steve, Green, Stephanie J., Garcia, Dava, Hannigan, Edward V., O'toole, Robert, Stock-Novack, Donna, Surwit, Earl A., Malviya, Vinay K., Jolles, Christopher J.
Zdroj: Cancer (0008543X); Jan1993 Supplement 2, Vol. 71 Issue S2, p618-627, 10p
Databáze: Complementary Index